Pharmacovigilance Market Report

Global and Regional Pharmacovigilance Market Details Research Report 2021-2026

  • POSTDATE：Jun 25, 2021
  • PAGES：197
  • REPORT CODE：GMM721421
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Pharmacovigilance Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Pharmacovigilance market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Pharmacovigilance market.

    By Player:

    • Clinquest Group BV

    • ICON plc

    • PRA Health Sciences Inc

    • Accenture Plc

    • GSK

    • Mapi Group

    • Chiltern

    • Eli Lilly and Company

    • Atlantic Research Group

    • Elsevier

    By Type:

    • Chemotherapy

    • Contract Outsourcing

    By End-User:

    • Pharma and Biotech Companies

    • Contract Research Organizations (CROs)

    • Business Process Outsourcing (BPO) Firms

    • Other Pharmacovigilance Service Providers

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Pharmacovigilance Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Pharmacovigilance Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Pharmacovigilance Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Pharmacovigilance Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Pharmacovigilance Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Pharmacovigilance Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Clinquest Group BV

      • 3.1.1 Clinquest Group BV - Company Business Overview

      • 3.1.2 Clinquest Group BV - Company Financial Performance

      • 3.1.3 Clinquest Group BV - Company Financial Performance of Pharmacovigilance

      • 3.1.4 Pharmacovigilance Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 ICON plc

      • 3.2.1 ICON plc - Company Business Overview

      • 3.2.2 ICON plc - Company Financial Performance

      • 3.2.3 ICON plc - Company Financial Performance of Pharmacovigilance

      • 3.2.4 Pharmacovigilance Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 PRA Health Sciences Inc

      • 3.3.1 PRA Health Sciences Inc - Company Business Overview

      • 3.3.2 PRA Health Sciences Inc - Company Financial Performance

      • 3.3.3 PRA Health Sciences Inc - Company Financial Performance of Pharmacovigilance

      • 3.3.4 Pharmacovigilance Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Accenture Plc

      • 3.4.1 Accenture Plc - Company Business Overview

      • 3.4.2 Accenture Plc - Company Financial Performance

      • 3.4.3 Accenture Plc - Company Financial Performance of Pharmacovigilance

      • 3.4.4 Pharmacovigilance Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 GSK

      • 3.5.1 GSK - Company Business Overview

      • 3.5.2 GSK - Company Financial Performance

      • 3.5.3 GSK - Company Financial Performance of Pharmacovigilance

      • 3.5.4 Pharmacovigilance Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Mapi Group

      • 3.6.1 Mapi Group - Company Business Overview

      • 3.6.2 Mapi Group - Company Financial Performance

      • 3.6.3 Mapi Group - Company Financial Performance of Pharmacovigilance

      • 3.6.4 Pharmacovigilance Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Chiltern

      • 3.7.1 Chiltern - Company Business Overview

      • 3.7.2 Chiltern - Company Financial Performance

      • 3.7.3 Chiltern - Company Financial Performance of Pharmacovigilance

      • 3.7.4 Pharmacovigilance Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Eli Lilly and Company

      • 3.8.1 Eli Lilly and Company - Company Business Overview

      • 3.8.2 Eli Lilly and Company - Company Financial Performance

      • 3.8.3 Eli Lilly and Company - Company Financial Performance of Pharmacovigilance

      • 3.8.4 Pharmacovigilance Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Atlantic Research Group

      • 3.9.1 Atlantic Research Group - Company Business Overview

      • 3.9.2 Atlantic Research Group - Company Financial Performance

      • 3.9.3 Atlantic Research Group - Company Financial Performance of Pharmacovigilance

      • 3.9.4 Pharmacovigilance Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Elsevier

      • 3.10.1 Elsevier - Company Business Overview

      • 3.10.2 Elsevier - Company Financial Performance

      • 3.10.3 Elsevier - Company Financial Performance of Pharmacovigilance

      • 3.10.4 Pharmacovigilance Product Benchmarking

      • 3.10.5 Strategic Initiatives

    4 Global Pharmacovigilance Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Pharmacovigilance Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Chemotherapy 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Contract Outsourcing 2016-2021

    • 4.3 Global Pharmacovigilance Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Chemotherapy 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Contract Outsourcing 2016-2021

    • 4.4 Global Pharmacovigilance Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Pharmacovigilance Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Pharmacovigilance Market Price By Type from 2016 to 2026

    5 Global Pharmacovigilance Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Pharmacovigilance

    • 5.2 Global Pharmacovigilance Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Pharma and Biotech Companies 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Contract Research Organizations (CROs) 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Business Process Outsourcing (BPO) Firms 2016-2021

      • 5.2.4 Global Revenue and Growth Rate of Other Pharmacovigilance Service Providers 2016-2021

    • 5.3 Global Pharmacovigilance Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Pharma and Biotech Companies 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Contract Research Organizations (CROs) 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Business Process Outsourcing (BPO) Firms 2016-2021

      • 5.3.4 Global Sales and Growth Rate of Other Pharmacovigilance Service Providers 2016-2021

    • 5.4 Global Pharmacovigilance Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Pharmacovigilance Market Sales and Market Share by Application (Forecast)

    6 Global Pharmacovigilance Market Segment Analysis (Geography Level)

    • 6.1 Global Pharmacovigilance Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Pharmacovigilance Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Pharmacovigilance Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Pharmacovigilance Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Pharmacovigilance Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Pharmacovigilance Market from 2016 to 2020

    7. North America Pharmacovigilance Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Pharmacovigilance Market Segment by Countries

      • 7.1.1 North America Pharmacovigilance Market Revenue Segment by Countries

      • 7.1.2 North America Pharmacovigilance Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Pharmacovigilance Market Segment (Product Type Level)

    • 7.3 North America Pharmacovigilance Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Pharmacovigilance Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Pharmacovigilance Market Segment by Countries

      • 8.1.1 Europe Pharmacovigilance Market Revenue Segment by Countries

      • 8.1.2 Europe Pharmacovigilance Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Pharmacovigilance Market Segment (Product Type Level)

    • 8.3 Europe Pharmacovigilance Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Pharmacovigilance Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Pharmacovigilance Market Segment by Countries

      • 9.1.1 Asia Pharmacovigilance Market Revenue Segment by Countries

      • 9.1.2 Asia Pharmacovigilance Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Pharmacovigilance Market Segment (Product Type Level)

    • 9.3 Asia Pharmacovigilance Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Pharmacovigilance Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Pharmacovigilance Market Segment by Countries

      • 10.1.1 South America Pharmacovigilance Market Revenue Segment by Countries

      • 10.1.2 South America Pharmacovigilance Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Pharmacovigilance Market Segment (Product Type Level)

    • 10.3 South America Pharmacovigilance Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Pharmacovigilance Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Pharmacovigilance Market Segment by Countries

      • 11.1.1 Middle East Pharmacovigilance Market Revenue Segment by Countries

      • 11.1.2 Middle East Pharmacovigilance Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Pharmacovigilance Market Segment (Product Type Level)

    • 11.3 Middle East Pharmacovigilance Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Pharmacovigilance Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Pharmacovigilance Market Segment by Countries

      • 12.1.1 Africa Pharmacovigilance Market Revenue Segment by Countries

      • 12.1.2 Africa Pharmacovigilance Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Pharmacovigilance Market Segment (Product Type Level)

    • 12.3 Africa Pharmacovigilance Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Pharmacovigilance Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Pharmacovigilance Market Segment by Countries

      • 13.1.1 Oceania Pharmacovigilance Market Revenue Segment by Countries

      • 13.1.2 Oceania Pharmacovigilance Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Pharmacovigilance Market Segment (Product Type Level)

    • 13.3 Oceania Pharmacovigilance Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Pharmacovigilance Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Pharmacovigilance

      • 14.2.2 Manufacturing Process Analysis of Pharmacovigilance

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Pharmacovigilance Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Pharmacovigilance Industry Market Status, Pre-COVID-19

      • 15.5.3 Pharmacovigilance Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Pharmacovigilance Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Pharmacovigilance Product Picture

    • Table Pharmacovigilance Product Definition

    • Table Study Scope by Types

    • Figure Global Pharmacovigilance Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Pharmacovigilance Market Value by Application (2016 - 2026)

    • Figure Global Pharmacovigilance Market Size and Growth Rate from 2016 to 2026

    • Table Global Pharmacovigilance Production Capacity by Manufacturers (2016-2021)

    • Table Global Pharmacovigilance Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Pharmacovigilance Revenue by Manufacturers (2016-2021)

    • Table Global Pharmacovigilance Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Pharmacovigilance Plant Distribution and Sales Country

    • Table Clinquest Group BV - Company Business Overview

    • Figure Clinquest Group BV Total Revenue from 2018 to 2020

    • Table Clinquest Group BV Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Clinquest Group BV Sales and Growth Rate Analysis of Pharmacovigilance

    • Figure Revenue and Market Share Analysis of Clinquest Group BV

    • Table Pharmacovigilance Product Benchmarking

    • Table ICON plc - Company Business Overview

    • Figure ICON plc Total Revenue from 2018 to 2020

    • Table ICON plc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure ICON plc Sales and Growth Rate Analysis of Pharmacovigilance

    • Figure Revenue and Market Share Analysis of ICON plc

    • Table Pharmacovigilance Product Benchmarking

    • Table PRA Health Sciences Inc - Company Business Overview

    • Figure PRA Health Sciences Inc Total Revenue from 2018 to 2020

    • Table PRA Health Sciences Inc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure PRA Health Sciences Inc Sales and Growth Rate Analysis of Pharmacovigilance

    • Figure Revenue and Market Share Analysis of PRA Health Sciences Inc

    • Table Pharmacovigilance Product Benchmarking

    • Table Accenture Plc - Company Business Overview

    • Figure Accenture Plc Total Revenue from 2018 to 2020

    • Table Accenture Plc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Accenture Plc Sales and Growth Rate Analysis of Pharmacovigilance

    • Figure Revenue and Market Share Analysis of Accenture Plc

    • Table Pharmacovigilance Product Benchmarking

    • Table GSK - Company Business Overview

    • Figure GSK Total Revenue from 2018 to 2020

    • Table GSK Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GSK Sales and Growth Rate Analysis of Pharmacovigilance

    • Figure Revenue and Market Share Analysis of GSK

    • Table Pharmacovigilance Product Benchmarking

    • Table Mapi Group - Company Business Overview

    • Figure Mapi Group Total Revenue from 2018 to 2020

    • Table Mapi Group Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Mapi Group Sales and Growth Rate Analysis of Pharmacovigilance

    • Figure Revenue and Market Share Analysis of Mapi Group

    • Table Pharmacovigilance Product Benchmarking

    • Table Chiltern - Company Business Overview

    • Figure Chiltern Total Revenue from 2018 to 2020

    • Table Chiltern Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Chiltern Sales and Growth Rate Analysis of Pharmacovigilance

    • Figure Revenue and Market Share Analysis of Chiltern

    • Table Pharmacovigilance Product Benchmarking

    • Table Eli Lilly and Company - Company Business Overview

    • Figure Eli Lilly and Company Total Revenue from 2018 to 2020

    • Table Eli Lilly and Company Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Eli Lilly and Company Sales and Growth Rate Analysis of Pharmacovigilance

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company

    • Table Pharmacovigilance Product Benchmarking

    • Table Atlantic Research Group - Company Business Overview

    • Figure Atlantic Research Group Total Revenue from 2018 to 2020

    • Table Atlantic Research Group Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Atlantic Research Group Sales and Growth Rate Analysis of Pharmacovigilance

    • Figure Revenue and Market Share Analysis of Atlantic Research Group

    • Table Pharmacovigilance Product Benchmarking

    • Table Elsevier - Company Business Overview

    • Figure Elsevier Total Revenue from 2018 to 2020

    • Table Elsevier Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Elsevier Sales and Growth Rate Analysis of Pharmacovigilance

    • Figure Revenue and Market Share Analysis of Elsevier

    • Table Pharmacovigilance Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Pharmacovigilance Market Revenue by Types (Historical)

    • Table Global Pharmacovigilance Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Chemotherapy 2016-2021

    • Figure Global Revenue and Growth Rate of Contract Outsourcing 2016-2021

    • Table Global Pharmacovigilance Market Sales by Types (Historical)

    • Table Global Pharmacovigilance Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Chemotherapy 2016-2021

    • Figure Global Sales and Growth Rate of Contract Outsourcing 2016-2021

    • Table Global Pharmacovigilance Market Revenue by Types (Forecast)

    • Table Global Pharmacovigilance Market Revenue Market Share by Types (Forecast)

    • Table Global Pharmacovigilance Market Sales by Types (Forecast)

    • Table Global Pharmacovigilance Market Sales Market Share by Types (Forecast)

    • Figure Global Pharmacovigilance Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Pharmacovigilance

    • Table Global Pharmacovigilance Market Revenue by Application (Historical)

    • Table Global Pharmacovigilance Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Pharma and Biotech Companies 2016-2021

    • Figure Global Revenue and Growth Rate of Contract Research Organizations (CROs) 2016-2021

    • Figure Global Revenue and Growth Rate of Business Process Outsourcing (BPO) Firms 2016-2021

    • Figure Global Revenue and Growth Rate of Other Pharmacovigilance Service Providers 2016-2021

    • Table Global Pharmacovigilance Market Sales by Application (Historical)

    • Table Global Pharmacovigilance Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Pharma and Biotech Companies 2016-2021

    • Figure Global Sales and Growth Rate of Contract Research Organizations (CROs) 2016-2021

    • Figure Global Sales and Growth Rate of Business Process Outsourcing (BPO) Firms 2016-2021

    • Figure Global Sales and Growth Rate of Other Pharmacovigilance Service Providers 2016-2021

    • Table Global Pharmacovigilance Market Revenue by Application (Forecast)

    • Table Global Pharmacovigilance Market Revenue Market Share by Application (Forecast)

    • Table Global Pharmacovigilance Market Sales by Application (Forecast)

    • Table Global Pharmacovigilance Market Sales Market Share by Application (Forecast)

    • Table Global Pharmacovigilance Market Revenue by Geography (Historical)

    • Table Global Pharmacovigilance Market Revenue Market Share by Geography (Historical)

    • Figure Global Pharmacovigilance Revenue Market Share by Geography in 2020

    • Table Global Pharmacovigilance Market Sales by Geography (Historical)

    • Table Global Pharmacovigilance Market Sales Market Share by Geography (Historical)

    • Figure Global Pharmacovigilance Sales Market Share by Geography in 2020

    • Table Global Pharmacovigilance Market Revenue by Geography (Forecast)

    • Table Global Pharmacovigilance Market Revenue Market Share by Geography (Forecast)

    • Table Global Pharmacovigilance Market Sales by Geography (Forecast)

    • Table Global Pharmacovigilance Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Pharmacovigilance Revenue by Countries from 2016 to 2026

    • Table North America Pharmacovigilance Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Pharmacovigilance Revenue Market Share by Major Countries in 2020

    • Table North America Pharmacovigilance Sales by Countries from 2016 to 2026

    • Table North America Pharmacovigilance Sales Market Share by Countries from 2016 to 2026

    • Figure North America Pharmacovigilance Sales Market Share by Major Countries in 2020

    • Figure USA Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure USA Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Table North America Pharmacovigilance Sales by Types from 2016 to 2026

    • Table North America Pharmacovigilance Sales Market Share by Types from 2016 to 2026

    • Table North America Pharmacovigilance Value by Types from 2016 to 2026

    • Table North America Pharmacovigilance Value Market Share by Types from 2016 to 2026

    • Table North America Pharmacovigilance Sales by Application from 2016 to 2026

    • Table North America Pharmacovigilance Sales Market Share by Application from 2016 to 2026

    • Table North America Pharmacovigilance Value by Application from 2016 to 2026

    • Table North America Pharmacovigilance Value Market Share by Application from 2016 to 2026

    • Table Europe Pharmacovigilance Revenue by Countries from 2016 to 2026

    • Table Europe Pharmacovigilance Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Pharmacovigilance Revenue Market Share by Major Countries in 2020

    • Table Europe Pharmacovigilance Sales by Countries from 2016 to 2026

    • Table Europe Pharmacovigilance Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Pharmacovigilance Sales Market Share by Major Countries in 2020

    • Figure Germany Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure France Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure France Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Pharmacovigilance Sales by Types from 2016 to 2026

    • Table Europe Pharmacovigilance Sales Market Share by Types from 2016 to 2026

    • Table Europe Pharmacovigilance Value by Types from 2016 to 2026

    • Table Europe Pharmacovigilance Value Market Share by Types from 2016 to 2026

    • Table Europe Pharmacovigilance Sales by Application from 2016 to 2026

    • Table Europe Pharmacovigilance Sales Market Share by Application from 2016 to 2026

    • Table Europe Pharmacovigilance Value by Application from 2016 to 2026

    • Table Europe Pharmacovigilance Value Market Share by Application from 2016 to 2026

    • Table Asia Pharmacovigilance Revenue by Countries from 2016 to 2026

    • Table Asia Pharmacovigilance Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Pharmacovigilance Revenue Market Share by Major Countries in 2020

    • Table Asia Pharmacovigilance Sales by Countries from 2016 to 2026

    • Table Asia Pharmacovigilance Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Pharmacovigilance Sales Market Share by Major Countries in 2020

    • Figure China Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure China Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure India Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure India Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Pharmacovigilance Sales by Types from 2016 to 2026

    • Table Asia Pharmacovigilance Sales Market Share by Types from 2016 to 2026

    • Table Asia Pharmacovigilance Value by Types from 2016 to 2026

    • Table Asia Pharmacovigilance Value Market Share by Types from 2016 to 2026

    • Table Asia Pharmacovigilance Sales by Application from 2016 to 2026

    • Table Asia Pharmacovigilance Sales Market Share by Application from 2016 to 2026

    • Table Asia Pharmacovigilance Value by Application from 2016 to 2026

    • Table Asia Pharmacovigilance Value Market Share by Application from 2016 to 2026

    • Table South America Pharmacovigilance Revenue by Countries from 2016 to 2026

    • Table South America Pharmacovigilance Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Pharmacovigilance Revenue Market Share by Major Countries in 2020

    • Table South America Pharmacovigilance Sales by Countries from 2016 to 2026

    • Table South America Pharmacovigilance Sales Market Share by Countries from 2016 to 2026

    • Figure South America Pharmacovigilance Sales Market Share by Major Countries in 2020

    • Figure Brazil Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Table South America Pharmacovigilance Sales by Types from 2016 to 2026

    • Table South America Pharmacovigilance Sales Market Share by Types from 2016 to 2026

    • Table South America Pharmacovigilance Value by Types from 2016 to 2026

    • Table South America Pharmacovigilance Value Market Share by Types from 2016 to 2026

    • Table South America Pharmacovigilance Sales by Application from 2016 to 2026

    • Table South America Pharmacovigilance Sales Market Share by Application from 2016 to 2026

    • Table South America Pharmacovigilance Value by Application from 2016 to 2026

    • Table South America Pharmacovigilance Value Market Share by Application from 2016 to 2026

    • Table Middle East Pharmacovigilance Revenue by Countries from 2016 to 2026

    • Table Middle East Pharmacovigilance Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Pharmacovigilance Revenue Market Share by Major Countries in 2020

    • Table Middle East Pharmacovigilance Sales by Countries from 2016 to 2026

    • Table Middle East Pharmacovigilance Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Pharmacovigilance Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Pharmacovigilance Sales by Types from 2016 to 2026

    • Table Middle East Pharmacovigilance Sales Market Share by Types from 2016 to 2026

    • Table Middle East Pharmacovigilance Value by Types from 2016 to 2026

    • Table Middle East Pharmacovigilance Value Market Share by Types from 2016 to 2026

    • Table Middle East Pharmacovigilance Sales by Application from 2016 to 2026

    • Table Middle East Pharmacovigilance Sales Market Share by Application from 2016 to 2026

    • Table Middle East Pharmacovigilance Value by Application from 2016 to 2026

    • Table Middle East Pharmacovigilance Value Market Share by Application from 2016 to 2026

    • Table Africa Pharmacovigilance Revenue by Countries from 2016 to 2026

    • Table Africa Pharmacovigilance Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Pharmacovigilance Revenue Market Share by Major Countries in 2020

    • Table Africa Pharmacovigilance Sales by Countries from 2016 to 2026

    • Table Africa Pharmacovigilance Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Pharmacovigilance Sales Market Share by Major Countries in 2020

    • Figure Nigeria Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Pharmacovigilance Sales by Types from 2016 to 2026

    • Table Africa Pharmacovigilance Sales Market Share by Types from 2016 to 2026

    • Table Africa Pharmacovigilance Value by Types from 2016 to 2026

    • Table Africa Pharmacovigilance Value Market Share by Types from 2016 to 2026

    • Table Africa Pharmacovigilance Sales by Application from 2016 to 2026

    • Table Africa Pharmacovigilance Sales Market Share by Application from 2016 to 2026

    • Table Africa Pharmacovigilance Value by Application from 2016 to 2026

    • Table Africa Pharmacovigilance Value Market Share by Application from 2016 to 2026

    • Table Oceania Pharmacovigilance Revenue by Countries from 2016 to 2026

    • Table Oceania Pharmacovigilance Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Pharmacovigilance Revenue Market Share by Major Countries in 2020

    • Table Oceania Pharmacovigilance Sales by Countries from 2016 to 2026

    • Table Oceania Pharmacovigilance Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Pharmacovigilance Sales Market Share by Major Countries in 2020

    • Figure Australia Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Pharmacovigilance Sales by Types from 2016 to 2026

    • Table Oceania Pharmacovigilance Sales Market Share by Types from 2016 to 2026

    • Table Oceania Pharmacovigilance Value by Types from 2016 to 2026

    • Table Oceania Pharmacovigilance Value Market Share by Types from 2016 to 2026

    • Table Oceania Pharmacovigilance Sales by Application from 2016 to 2026

    • Table Oceania Pharmacovigilance Sales Market Share by Application from 2016 to 2026

    • Table Oceania Pharmacovigilance Value by Application from 2016 to 2026

    • Table Oceania Pharmacovigilance Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Pharmacovigilance

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Pharmacovigilance with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US